ADDING APREPITANT TO A MULTIMODAL STRATEGY FOR PREVENTING POSTOPERATIVE NAUSEA AND VOMITING IN HIGH-RISK PATIENTS UNDERGOING OUTPATIENT SURGERY

Registry ID

2026-13145

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL

Start date

2026-02-02

Last update

2025-12-03

Conditions

• NAUSEA AND VOMITING

Related clinical trials

• A RANDOMIZED CONTROLLED TRIAL COMPARING APREPITANT TO STANDARD OF CARE FOR POSTOPERATIVE NAUSEA AND VOMITING PROPHYLAXIS IN CHILDREN UNDERGOING SCOLIOSIS SURGERY: THE APRE-PONV TRIAL
• RANDOMIZED, DOUBLE-BLIND, PHASE 2/3 STUDY OF IV AMISULPRIDE AS PREVENTION OF POST-OPERATIVE NAUSEA AND VOMITING IN PEDIATRIC PATIENTS
• RANDOMIZED CONTROLLED TRIAL OF OLANZAPINE FOR THE CONTROL OF CHEMOTHERAPY-INDUCED VOMITING IN CHILDREN RECEIVING CHEMOTHERAPY FOR HEMATOPOIETIC STEM CELL TRANSPLANT CONDITIONING

View on source registry